University Hospitals Birmingham NHS Foundation Trust

Medicines A–Z

E

Status Drug name NICE TAs Comments
Status: Red Econazole pessaries (Gyno-Pevaryl®)
Status: Green Edoxaban

First choice following a diagnosis of AF - use in line with NICE

Status: Amber Edoxaban

Specialist initiation - For the treatment and secondary prevention of DVT and/or PE - use in line with NICE and supported by RICaD

Status: Red Edrophonium chloride
Status: Red Eliglustat (Cerdelga®)

NHSE commissioned

Status: Red Elosulfase lfa (Vimizim®)

NHSE commissioned

Status: Red Eltrombopag tablets
Status: Amber Eluxadoline (Truberzi®)

To be used in line with NICE TA 471. Specialist initiation, and transfer prescribing to GP using RICaD (in development).

Status: Green Empagliflozin
Status: Amber Empagliflozin (Jardiance®)

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top